| 1 |
34983356 | Metainflammation in COVID-19. | 2022 Jan 4 |
1 |
| 2 |
35455823 | Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis. | 2022 Mar 30 |
1 |
| 3 |
33477294 | COVID-19-The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection. | 2021 Jan 17 |
2 |
| 4 |
33708781 | Effect of Spironolactone on COVID-19 in Patients With Underlying Liver Cirrhosis: A Nationwide Case-Control Study in South Korea. | 2021 |
2 |
| 5 |
32721806 | Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS). | 2020 Oct |
1 |
| 6 |
33278189 | Is Spironolactone the Preferred Renin-Angiotensin-Aldosterone Inhibitor for Protection Against COVID-19? | 2020 Dec 4 |
2 |